Shengtai Pharmaceutical, Inc. a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, recently announced that it has received a "Good Manufacturing Practice" (GMP) certificate for its new glucose manufacturing facility. 

The certificate of compliance, issued by the government after a rigorous inspection process, certifies that pharmaceutical ingredients manufactured by Shengtai are produced and quality-controlled according to generally accepted standards.

The new glucose production facility has an annual production capacity of 120,000 tons. Combining this new capacity with our existing glucose plant, we have the ability to produce up to 180,000 tons of glucose on an annual basis and can be expanded up to 210,000 tons, if necessary. "The GMP certification is an important milestone for our glucose production process," said Ms. Yiru Melody Shi, Shengtai's Chief Financial Officer. "With this new glucose facility, we are now commencing operations in stages and will gradually ramp up production to expand our offerings to the pharmaceutical and food and beverage industry."